Depressive Disorder
Conditions
Brief summary
The purpose of this study is to validate the effectiveness of using an integrated mobile sensing platform to deliver large-scale data-driven interventions to patients with depression.
Detailed description
This study is a smartphone-based, randomized, single-blind, controlled parallel- design study with two intervention arms and one control arm. The two intervention arms will receive in-app messages and phone-based support, which will be triggered by participant's self-reported surveys and passive behavioral data gathered through a smartphone app. The study will include a nationwide sample of adult (18 years or older) smartphone users, who are currently experiencing depressive symptoms. The primary outcome will be decrease in depression symptom severity, as measured by the 9-item Patient Health Questionnaire, over 6 months.
Interventions
Phone-based support (e.g. triaging of the situation, emotional support, and guidance on next steps for the patient) and in-app support (health education content based on cognitive behavioral therapies, mindfulness, and behavioral activation)
Sponsors
Study design
Eligibility
Inclusion criteria
* Currently suffering from depression (as measured by a PHQ-9 score of 10 or more at the time of screening) * Own an iPhone or Android smartphone with a mobile voice calling plan with a US carrier * Fluency in English
Exclusion criteria
* Participants with visual or hearing impairment * Recent history of pregnancy (currently pregnant or those who have given birth within the past four months at the time of screening) * Recent loss of a loved one (within the past two months at the time of screening) * Unable or unwilling to accept End User License Agreement, or to provide information regarding their demographic characteristics and mental health history
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in depression symptom severity | 6 months | Change in the 9-item Patient Health Questionnaire (PHQ-9) score from baseline |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in patient activation | 6 months | Change in the 13-item Patient Activation Measure score from baseline |